1523P Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
Sezgin, Y., Karhan, O., Urakci, Z., Mecidova, N., Araz, M., Sakin, A., Ercek, B.M., Ürün, M., Urvay, S., Aykan, M.B., Kocak, S., Arici, M.O., Avci, N., Alkan, A., Ozcelik, M., Aldemir, M.N., Ergün, Y.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
67P Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma
Yildirim, H.C., Bayram, E., Chalabiyev, E., Mecidova, N., Avci, T., Güzel, H.G., Kapar, C., Uzun, M., Perkin, P., Akgül, F., Yildirim, S.S.I.M., Sali, S., Yildiz, A., Kazaz, S.N., Hendem, E., Arcagök, M., Tufan, G., Akgül, Ö.F., Arslan, C., Erman, M.
Published in ESMO open (01.02.2024)
Published in ESMO open (01.02.2024)
Get full text
Journal Article
68P Real-world clinical and treatment-related outcomes in specific subgroups of patients with BRAF-positive metastatic melanoma treated with dabrafenib-trametinib: Turkish Oncology Group study
Yildirim, E. Caliskan, Semiz, H.S., Akyildiz, A., Yaslikaya, S., Sanci, P. Can, Guliyev, M., Sertesen, E., Akdag, G., Ozcan, E., Mecidova, N., Ugrakli, M., Demirci, N.S., Kefeli, U., Paydas, S., Ates, O., Cicin, I., Yildirim, M.E., Dizdar, O., Celik, I., Karaoglu, A.
Published in ESMO open (01.02.2024)
Published in ESMO open (01.02.2024)
Get full text
Journal Article